Table: Rohto -2017/18 group results

Rohto Pharmaceutical

11/05/2018 07:00

May 11 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            171.74          154.60         176.00                 
                 (+11.1 pct)     (-7.4 pct)     (+2.5 pct)               
  Operating         19.09           15.45          19.50                 
                 (+23.5 pct)     (-1.5 pct)     (+2.2 pct)               
  Recurring         18.85           15.96          19.60                 
                 (+18.1 pct)     (+4.1 pct)     (+4.0 pct)               
  Net
  Net                9.29           10.01          11.90                 
                 (-7.2 pct)      (+10.0 pct)    (+28.1 pct)              
  EPS             81.55 yen       87.95 yen     104.46 yen               
  EPS Diluted     81.20 yen       87.57 yen                              
  Ann Div         22.00 yen       21.00 yen      23.00 yen               
  -Q2 Div         11.00 yen       10.00 yen      11.00 yen               
  -Q4 Div         11.00 yen       11.00 yen      12.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T